|
| ID |
DDInter392 |
| Drug Type |
small molecule |
| Molecular Formula |
C10H12Cln5O3 |
| Molecular Weight |
285.691
|
| Description |
Cladribine is a purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs.
|
| ATC Classification |
L04AA40
L01BB04
|
| IUPAC Name |
(2R,3S,5R)-5-(6-Amino-2-Chloro-9H-Purin-9-Yl)-2-(Hydroxymethyl)Oxolan-3-Ol |
| InChI |
Inchi=1S/C10H12Cln5O3/C11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/H3-6,17-18H,1-2H2,(H2,12,14,15)/T4-,5+,6+/M0/S1 |
| InChI Key |
PTOAARAWEBMLNO-KVQBGUIXSA-N |
| Canonical SMILES |
NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|